The Advanced Wound Care segment focuses on developing and marketing innovative wound dressings and skin care products for managing acute and chronic wounds. This includes wounds resulting from diabetes, immobility, venous disease, traumatic injury, burns, and surgery. Research and development efforts are directed towards creating advanced materials and technologies that promote faster healing, reduce infection risk, and improve patient comfort. Key technologies include hydrocolloids, foams, films, and antimicrobial dressings. Clinical studies are conducted to validate the efficacy and cost-effectiveness of these products. The segment addresses a significant patient need, particularly among the elderly and those with chronic conditions, and aims to reduce healthcare costs associated with wound management. Future opportunities include expanding into new markets and developing more advanced wound healing solutions.

The Ostomy Care segment provides devices, accessories, and services for individuals with a stoma resulting from conditions like colorectal cancer, inflammatory bowel disease, and bladder cancer. This segment focuses on improving the quality of life for ostomates through innovative product design and patient support programs. Research and development efforts are centered on creating more comfortable, discreet, and user-friendly ostomy systems. Technologies include advanced adhesives, odor-control materials, and ergonomic pouch designs. The segment also emphasizes patient education and support, offering resources and services to help individuals manage their ostomies effectively. Market positioning is focused on providing a comprehensive range of products and services to meet the diverse needs of ostomates. Future growth opportunities include expanding into emerging markets and developing new technologies to further enhance the patient experience.

The Continence and Critical Care segment offers products for urinary continence issues and devices for intensive care units. This includes intermittent urological catheters and products for individuals with spinal cord injuries, multiple sclerosis, and other urological disorders. The segment also provides advanced systems for managing fecal incontinence and monitoring urine production and intra-abdominal pressure. Research and development activities focus on improving catheter design, developing more effective continence management solutions, and enhancing patient monitoring technologies. The segment addresses critical needs in both hospital and home healthcare settings, aiming to improve patient outcomes and reduce healthcare costs. Future opportunities include expanding into new markets and developing more advanced technologies for continence management and critical care monitoring.

The Infusion Care segment provides disposable infusion sets to manufacturers of insulin pumps for diabetes and similar pumps used in continuous infusion treatments for other conditions. This segment focuses on developing high-quality, reliable infusion sets that ensure accurate and consistent drug delivery. Research and development efforts are directed towards improving infusion set design, enhancing patient comfort, and reducing the risk of infusion site complications. The segment partners with leading insulin pump manufacturers to provide integrated solutions for diabetes management. Market positioning is focused on being a trusted supplier of infusion sets to the diabetes care market. Future growth opportunities include expanding into new therapeutic areas and developing more advanced infusion technologies.